
Nanoscale Advances, Год журнала: 2023, Номер 5(23), С. 6382 - 6399
Опубликована: Янв. 1, 2023
Cancer causes one in six deaths worldwide, and 1.6 million cancer patients face annual out-of-pocket medical expenditures.
Язык: Английский
Nanoscale Advances, Год журнала: 2023, Номер 5(23), С. 6382 - 6399
Опубликована: Янв. 1, 2023
Cancer causes one in six deaths worldwide, and 1.6 million cancer patients face annual out-of-pocket medical expenditures.
Язык: Английский
Plasmonics, Год журнала: 2025, Номер unknown
Опубликована: Янв. 10, 2025
Язык: Английский
Процитировано
18Plasmonics, Год журнала: 2025, Номер unknown
Опубликована: Янв. 27, 2025
Язык: Английский
Процитировано
2Journal of Biotechnology, Год журнала: 2025, Номер 400, С. 29 - 47
Опубликована: Фев. 15, 2025
Язык: Английский
Процитировано
2Plasmonics, Год журнала: 2025, Номер unknown
Опубликована: Март 13, 2025
Язык: Английский
Процитировано
2ACS Omega, Год журнала: 2024, Номер 9(23), С. 24181 - 24202
Опубликована: Май 30, 2024
Optical biosensors exhibit immense potential, offering extraordinary possibilities for biosensing due to their high sensitivity, reusability, and ultrafast sensing capabilities. This review provides a concise overview of optical biosensors, encompassing various platforms, operational mechanisms, underlying physics, it summarizes recent advancements in the field. Special attention is given plasmonic metasurface-based emphasizing significant performance bioassays and, thus, increasing attraction research, positioning them as excellent candidates lab-on-chip point-of-care devices. For we emphasize surface plasmon resonance (SPR) its subcategories, along with localized (LSPR) devices enhance Raman spectroscopy (SERS), highlighting ability perform diverse bioassays. Additionally, discuss recently emerged biosensors. Toward conclusion this review, address current challenges, opportunities, prospects biosensing. Considering advantages presented by foreseeable that they will become robust widespread platform early disease diagnostics.
Язык: Английский
Процитировано
14Plasmonics, Год журнала: 2024, Номер unknown
Опубликована: Июнь 29, 2024
Язык: Английский
Процитировано
14Plasmonics, Год журнала: 2024, Номер unknown
Опубликована: Июль 27, 2024
Язык: Английский
Процитировано
14Sensing and Imaging, Год журнала: 2025, Номер 26(1)
Опубликована: Март 15, 2025
Язык: Английский
Процитировано
1Optics & Laser Technology, Год журнала: 2025, Номер 188, С. 112899 - 112899
Опубликована: Апрель 9, 2025
Язык: Английский
Процитировано
1Physica Scripta, Год журнала: 2024, Номер 99(10), С. 105541 - 105541
Опубликована: Авг. 28, 2024
Abstract Breast cancer is the leading malignancy in women and 2nd widespread globally. Earlier identification of breast can improve treatment outcomes prevent metastasis beyond breast. Traditional screening tests are not sensitive enough for early diagnosis have extended detection periods. Recent studies explored diversified biosensor techniques, including optical, electrical, electrochemical, mechanical biosensors. This paper nominates a circlet with large plus sign refraction indices evaluation two distinct cells namely, MDA-MB-231 MCF-7. The supreme sensitivity has been viewed as 1714.28 nm/RIU quality factor (QF) value UC1(usual cell MDA-MB-231) 10.52, CC1(cancer 11.94, UC2 (usual MCF-7) 10.64, CC2 (cancer 12.09. minimal (DL) UC1 0.1573, CC1 0.1360, 0.1554, 0.1341. nominated sensor potential to sense tumor biomarkers.
Язык: Английский
Процитировано
8